Showing 67,621 - 67,640 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.35s Refine Results
  1. 67621

    Table_3_Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.pdf by Jiazhen Zou (19739203)

    Published 2024
    “…</p>Results<p>Univariate logistic regression analysis found significant correlations between NAFLD and specific urinary phthalate metabolites, such as Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and Mono-(carboxyisoctyl) phthalate (MCiOP), across different diagnostic criteria. …”
  2. 67622

    Image_3_Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.pdf by Jiazhen Zou (19739203)

    Published 2024
    “…</p>Results<p>Univariate logistic regression analysis found significant correlations between NAFLD and specific urinary phthalate metabolites, such as Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and Mono-(carboxyisoctyl) phthalate (MCiOP), across different diagnostic criteria. …”
  3. 67623

    Image_1_Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.pdf by Jiazhen Zou (19739203)

    Published 2024
    “…</p>Results<p>Univariate logistic regression analysis found significant correlations between NAFLD and specific urinary phthalate metabolites, such as Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and Mono-(carboxyisoctyl) phthalate (MCiOP), across different diagnostic criteria. …”
  4. 67624

    Image_2_Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.pdf by Jiazhen Zou (19739203)

    Published 2024
    “…</p>Results<p>Univariate logistic regression analysis found significant correlations between NAFLD and specific urinary phthalate metabolites, such as Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and Mono-(carboxyisoctyl) phthalate (MCiOP), across different diagnostic criteria. …”
  5. 67625

    Table_2_Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.pdf by Jiazhen Zou (19739203)

    Published 2024
    “…</p>Results<p>Univariate logistic regression analysis found significant correlations between NAFLD and specific urinary phthalate metabolites, such as Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Mono-2-ethyl-5-carboxypentyl phthalate (MECPP), and Mono-(carboxyisoctyl) phthalate (MCiOP), across different diagnostic criteria. …”
  6. 67626

    Degradation of the A2 PrLD and stability of the Sup35 ND upon insertion of hydrophobic residues do not depend on the Sup35 oligopeptide repeat domain (ORD), M-domain, or C-domain. by Sean M. Cascarina (525186)

    Published 2018
    “…<p>Progressively increasing hydrophobic content in the A2 PrLD (A) when fused to GFP alone (<i>top</i>) or with the remainder of the Sup35NM domains and tandem FLAG tags (<i>bottom</i>) enhances degradation rate of the A2 PrLD fusion proteins. …”
  7. 67627

    DataSheet1_The impact of combined administration of ropivacaine and dexamethasone on postoperative analgesia in perianal surgery with pudendal nerve block under ultrasound guidance... by Tao-Ran Yang (18890788)

    Published 2024
    “…proj=130226), and patients were randomly divided into two groups: one group underwent postoperative 20 mL bilateral pudendal nerve block with 0.5% ropivacaine (P group), and the other group underwent postoperative 20 mL bilateral pudendal nerve block with 0.5% ropivacaine + 8 mg dexamethasone (PD group). …”
  8. 67628

    A Novel Insulin Receptor-Binding Protein from <i>Momordica charantia</i> Enhances Glucose Uptake and Glucose Clearance in Vitro and in Vivo through Triggering Insulin Receptor Sign... by Hsin-Yi Lo (180409)

    Published 2014
    “…Intraperitoneal injection of 2.5 nmol/kg mcIRBP significantly decreased the blood glucose levels by 20.9 ± 3.2% and 10.8 ± 3.6% in normal and diabetic mice, respectively. …”
  9. 67629

    DataSheet2_The impact of combined administration of ropivacaine and dexamethasone on postoperative analgesia in perianal surgery with pudendal nerve block under ultrasound guidance... by Tao-Ran Yang (18890788)

    Published 2024
    “…proj=130226), and patients were randomly divided into two groups: one group underwent postoperative 20 mL bilateral pudendal nerve block with 0.5% ropivacaine (P group), and the other group underwent postoperative 20 mL bilateral pudendal nerve block with 0.5% ropivacaine + 8 mg dexamethasone (PD group). …”
  10. 67630

    Data_Sheet_1_Daytime Central Thalamic Deep Brain Stimulation Modulates Sleep Dynamics in the Severely Injured Brain: Mechanistic Insights and a Novel Framework for Alpha-Delta Slee... by Jackie L. Gottshall (6291503)

    Published 2019
    “…We now present novel findings that many of these improvements in sleep electrophysiology regress following CT-DBS discontinuation; these regressions in sleep features correlate with a significant decrease in behavioral responsiveness. …”
  11. 67631

    DataSheet1_A frequent CYP2D6 variant promotes skipping of exon 3 and reduces CYP2D6 protein expression in human liver samples.PDF by Joseph M. Collins (523015)

    Published 2023
    “…Here, using fragment analysis and RT-qPCR, we revealed that rs1058164 G (MAF = 27%–43%) is associated with increased formation of CYP2D6∆E3 in human liver samples (1.4–2.5-fold) and transfected cells. Furthermore, western blots showed that rs1058164 G was associated with a 50% decrease in full-length hepatic CYP2D6 protein expression. …”
  12. 67632

    Data_Sheet_1_Spatial and Temporal Trends in HIV/AIDS Burden Among Worldwide Regions From 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019.docx by Huan He (548057)

    Published 2022
    “…Purpose<p>HIV/AIDS is a critical public health concern worldwide. This article investigated the spatial and temporal trends in HIV/AIDS burden from 1990 to 2019.…”
  13. 67633

    Data_Sheet_1_Prevalence and incidence of stroke, white matter hyperintensities, and silent brain infarcts in patients with chronic heart failure: A systematic review, meta-analysis... by Sean Tan (13796668)

    Published 2022
    “…Subgroup analysis of HFpEF and HFrEF revealed a pooled prevalence of 2.97% (95% CI: 2.01–4.39) and 3.69% (95% CI: 2.34–5.77), respectively. …”
  14. 67634
  15. 67635

    Table1_Efficacy and safety of traditional Chinese medicine for intracranial hemorrhage by promoting blood circulation and removing blood stasis: A systematic review and meta-analys... by Wenjian Lin (9774764)

    Published 2022
    “…The pooled outcomes indicated that BACM combined with western medicine treatment (WMT) was superior to WMT alone for patients with ICH, demonstrated by the improvements in efficacy (RR = 1.22 (95% CI, [1.13 to 1.32], p < 0.001), neurological functions (MD<sub>NIHSS</sub> = −2.75, 95% CI [−3.74 to −1.76], p < 0.001), and activities of daily living (MD<sub>Barthel index</sub> = 5.95, 95% CI [3.92 to 7.98], p < 0.001), as well as decreased cerebral hematoma, cerebral edema (MD cerebral hematoma = −2.94, 95% CI [−3.50 to −2.37, p < 0.001 and MD<sub>cerebral edema</sub> = −2.66, 95% CI [−2.95 to −2.37], p < 0.001), side effects and mortality (RR = 0.84 (95% CI [0.60 to 1.19], p = 0.330 and RR = 0.51 (95% CI, [0.16 to 1.65], p = 0.260). …”
  16. 67636
  17. 67637

    Data_Sheet_1_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network... by Jie Zhang (64655)

    Published 2022
    “…According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”
  18. 67638

    Megakaryocyte number and myeloid: erythroid ratio in intact control (I−R) and irradiated (I+R) mice estimated by a board certified veterinary clinical pathologist (LS) according to... by Susanta K. Hui (304411)

    Published 2013
    “…Numerical scale: −4 severely decreased, −3 markedly decreased, −2 moderately decreased, −1 mildly decreased, +1 mildly increased, +2 moderately increased, +3 markedly increased, +4 severely increased, normal assigned a value of 0 for statistical calculations. …”
  19. 67639

    Data_Sheet_1_A Comparative Interrupted Times Series on the Health Impact of Probiotic Yogurt Consumption Among School Children From Three to Six Years Old in Southwest Uganda.DOCX by Nieke Westerik (3515327)

    Published 2020
    “…</p><p>Results: Over the course of the study period the incidence rate for common cold symptoms decreased faster in the yogurt group than in the milk group (p = 0.09) resulting in a final RR of 0.85 (95% CI: 0.5–1.4) at the end of the observational period. …”
  20. 67640